Sam Grant founded Unicorn Pacific Marketing with his father, Sam Grant Sr., nearly 40 years ago. Their mission was to manufacture and distribute TBL-12 — a product used to treat Sam Grant Sr.’s terminal stomach cancer in 1962 — and help other people around the globe who are facing a cancer diagnosis. Prior to forming PMB, Sam took TBL-12 through US-based FDA clinical trials for multiple myeloma and was granted Orphan Drug designation in 2012. It is one of a handful of products to have orphan designation to treat specific cancer patients.